Featured Research

from universities, journals, and other organizations

Controversial cholesterol guidelines biggest change in 25 years

Date:
November 14, 2013
Source:
Loyola University Health System
Summary:
New cholesterol guidelines for identifying adults at risk for heart disease represent the biggest change in such expert advice in more than 25 years, and could dramatically affect how patients are treated.

New cholesterol guidelines for identifying adults at risk for heart disease represent the biggest change in such expert advice in more than 25 years, according to Loyola University Health System preventive cardiology experts.

"This is very big news," said Binh An P. Phan, MD, director of Loyola's Preventive Cardiology and Lipid Program. "These new guidelines could dramatically affect how cholesterol is treated."

Under the guidelines, patients generally would be put on a cholesterol-reducing statin medication based on a formula that estimates their risk for cardiovascular disease. This is a major change from previous guidelines that placed more emphasis on patients' cholesterol numbers.

The clinical practice guidelines were issued by the American College of Cardiology and American Heart Association. They are intended to better identify adults who may be at risk for cardiovascular disease and who thus may benefit from lifestyle changes or statin cholesterol medications.

The guidelines could simplify the process of identifying patients who could benefit from statin therapy, said Loyola cardiologist Ivan V. Pacold, MD, an expert in preventive cardiology. Dr. Pacold is medical director of Cardiology at Loyola's Gottlieb Memorial Hospital.

"The guidelines emphasize that starting and keeping patients on statin treatment is more important than looking at the actual cholesterol-lowering effect of the treatment," Dr. Pacold said.

However, the guidelines are controversial. They have not been endorsed by the National Lipid Association, a multidisciplinary medical society that focuses on controlling cholesterol.

The guidelines are intended to meet the needs of patients in most circumstances. They are not meant to be a replacement for clinical judgment.

"For the many questions regarding complex lipid (cholesterol) disorders that are beyond the scope of our systemic evidence review, or which little or no RCT [randomized clinical trial] data are available, it is anticipated that clinicians with lipid expertise can contribute to their management," the guidelines say.

Cardiologists in Loyola's Preventive Cardiology and Lipid Program have special expertise in preventive cardiology and are board-certified in the field of lipidology and advanced cholesterol management by the American Board of Clinical Lipidology.


Story Source:

The above story is based on materials provided by Loyola University Health System. Note: Materials may be edited for content and length.


Cite This Page:

Loyola University Health System. "Controversial cholesterol guidelines biggest change in 25 years." ScienceDaily. ScienceDaily, 14 November 2013. <www.sciencedaily.com/releases/2013/11/131114101925.htm>.
Loyola University Health System. (2013, November 14). Controversial cholesterol guidelines biggest change in 25 years. ScienceDaily. Retrieved August 21, 2014 from www.sciencedaily.com/releases/2013/11/131114101925.htm
Loyola University Health System. "Controversial cholesterol guidelines biggest change in 25 years." ScienceDaily. www.sciencedaily.com/releases/2013/11/131114101925.htm (accessed August 21, 2014).

Share This




More Health & Medicine News

Thursday, August 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Drug Used To Treat 'Ebola's Cousin' Shows Promise

Newsy (Aug. 21, 2014) An experimental drug used to treat Marburg virus in rhesus monkeys could give new insight into a similar treatment for Ebola. Video provided by Newsy
Powered by NewsLook.com
Cadavers, a Teen, and a Medical School Dream

Cadavers, a Teen, and a Medical School Dream

AP (Aug. 21, 2014) Contains graphic content. He's only 17. But Johntrell Bowles has wanted to be a doctor from a young age, despite the odds against him. He was recently the youngest participant in a cadaver program at the Indiana University NW medical school. (Aug. 21) Video provided by AP
Powered by NewsLook.com
American Ebola Patients Released: What Cured Them?

American Ebola Patients Released: What Cured Them?

Newsy (Aug. 21, 2014) It's unclear whether the American Ebola patients' recoveries can be attributed to an experimental drug or early detection and good medical care. Video provided by Newsy
Powered by NewsLook.com
Lost Brain Cells To Blame For Sleep Problems Among Seniors

Lost Brain Cells To Blame For Sleep Problems Among Seniors

Newsy (Aug. 21, 2014) According to a new study, elderly people might have trouble sleeping because of the loss of a certain group of neurons in the brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins